Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 1 filing we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 23 most recent Form 4 transactions.
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 44,982 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 29,074 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 29,073 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 84,051 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 141,205 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 70,279 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 2,328 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 5,032 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 3,421 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 47,573 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 20,000 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 20,000 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 20,000 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 152,616 | — | — | -100.0% | Open the original filing on SEC.gov |
| Nov 26, 2025 | AKRO | Akero Therapeutics, Inc. | GGIFT | 9,259 | — | — | -4.4% | Open the original filing on SEC.gov |
| Nov 24, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 4,739 | — | — | — | Open the original filing on SEC.gov |
| Nov 24, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 3,527 | — | — | — | Open the original filing on SEC.gov |
| Nov 24, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 4,284 | — | — | — | Open the original filing on SEC.gov |
| Nov 24, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 4,739 | $21.10 | $100K | +2.3% | Open the original filing on SEC.gov |
| Nov 24, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 3,527 | $28.35 | $100K | +1.8% | Open the original filing on SEC.gov |
| Nov 24, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 4,284 | $21.09 | $90.3K | +2.2% | Open the original filing on SEC.gov |